Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azstarys in Children 4 and 5 Years of Age With ADHD
NCT05721235Phase 4Completed
- Sponsor
- Corium
- Start
- Jun 2023
- Primary completion
- Jul 2025
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of serdexmethylphenidate, dexmethylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Corium. Started Jun 2023; status: completed.
02
Drugs
serdexmethylphenidatedexmethylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT05721235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05721235.